Search clinical trials for: paclitaxel drug-eluting devices

Total 6543 results

University of Jena
Boston Scientific Corporation; Abbott Medical Devices; B. Braun Melsungen AG

Completed

Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everolimus-Eluting Coronary Stents (OCTOPUS)

Stents | Neointimal Proliferation

Germany
Nantes University Hospital
Boston Scientific Corporation; Cook Research Incorporated; French-Speaking Vascular...

Recruiting

The DETECT Project (DETECT)

Femoropopliteal Atheromatous Lesions

France
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Recruiting

Sirolimus DEB in Coronary Bifurcation Lesions

Coronary Bifurcation Lesions

China
Universitätsklinikum Hamburg-Eppendorf
BARMER; GermanVasc; MDEpiNet Verband Deutschland e.V.

Not yet recruiting

Analysis of Linked Health Insurance Claims and Clinical Registries to Determine Device Surveillance With Paclitaxel-coated Medical Devices (PacliVasc)

Outcome, Fatal | Paclitaxel Adverse Reaction
Xijing Hospital

Active, not recruiting

Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

Coronary Artery Disease | De Novo Stenosis

China
Abbott Medical Devices

Completed

Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study (OPTIMIZE BTK)

Vascular Calcification | PAD

Austria, Germany
Beth Israel Deaconess Medical Center
Boston Scientific Corporation; Medtronic; Philips Healthcare; Bard Peripheral Vascular... and other collaborators

Active, not recruiting

Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study) (SAFE-PAD)

Peripheral Arterial Disease | Safety Issues | Paclitaxel Adverse Reaction

United States
Lahey Clinic
National Evaluation System for health Technology Coordinating Center (NESTcc) and other collaborators

Completed

Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease

Peripheral Arterial Disease

United States
Spectranetics Corporation

Completed

ILLUMENATE EU Randomized Clinical Trial (EU RCT)

Peripheral Arterial Disease | Claudication

Germany
Hemoteq AG
CERES GmbH; coreLab Black Forest GmbH

Completed

Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Claudication

Germany, Austria, France
Fundación Pública Andaluza Progreso y Salud

Completed

Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon (FISBAL)

Arteriovenous Fistula Renal Dialysis Devices Obstruction

Spain
Deutsches Herzzentrum Muenchen

Completed

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES (ISAR-DESIRE 3A)

Coronary Restenosis

Germany
Assistance Publique - Hôpitaux de Paris
Boston Scientific Corporation

Unknown

An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK) (RANGER-BTK)

Peripheral Vascular Diseases | Lower Limb Ischemia

France
Cook Group Incorporated

Completed

Zilver Flex Post-Market Study in Japan

Peripheral Arterial Disease (PAD)

Japan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis (RESTORE)

Coronary Restenosis

Korea, Republic of
Maasstad Hospital

Completed

A Trial of Everolimus-eluting Stents and Paclitaxel-eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (COMPARE 1)

Acute Coronary Syndrome | Stable Angina | Unstable Angina

Netherlands
Abbott Medical Devices

Completed

EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Boston Scientific Corporation

Completed

TAXUS PERSEUS Workhorse (PERSEUS WH)

Coronary Artery Disease

United States, Australia, New Zealand, Singapore
Ospedale San Donato

Unknown

Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb Ischemia

Critical Limb Ischemia

Italy
Leonardo Bolognese, MD

Completed

Drug Eluting Balloon in peripherAl inTErvention SFA (DEBATE SFA)

Peripheral Arterial Disease

Italy
Abbott Medical Devices

Completed

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Coronary Artery Disease

United States
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS V)

In-Stent Restenosis

Spain
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Medical University of Vienna

Unknown

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial) (PACUBA 1)

Peripheral Arterial Disease

Austria
University Hospital Freiburg
Cordis Medizinische Apparate GmbH

Completed

Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)

Coronary Artery Disease

Germany
Anhui Provincial Cancer Hospital
Hutchison Medipharma Limited

Recruiting

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Ovarian Cancer

China
Shanghai Jiaolian Drug Research and Development...
Shanghai Pharmaceuticals Holding Co., Ltd

Not yet recruiting

A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Platinum-resistant Recurrent Ovarian Cancer

China
Abbott Medical Devices

Recruiting

Acute Response to Left Bundle Branch Area Pacing With SyncAV

Heart Failure

Italy
University of Southern Denmark
Odense University Hospital; Sygehus Lillebaelt; Sonderborg Hospital; Esbjerg Hospital

Not yet recruiting

Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations

Non-Small Cell Lung Cancer With HER2- Mutations

China
Louisiana State University Health Sciences Center...

Recruiting

Investigation Of Bioabsorbable Screws In Pediatric Orthopedic Surgery

Patient Satisfaction | Fracture | Pediatric | Orthopedic Devices Associated With Misadventures, Surgical Instruments, Materials and Devices (Including Sutures)

United States
Peking University Third Hospital
Jilin Provincial Tumor Hospital; Affiliated Hospital of Hebei University; Hebei...

Not yet recruiting

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Cervical Cancer
Assiut University

Not yet recruiting

Mechanical Thrombectomy of Acute Ischemic Stroke Anterior Circulation Distal Vessel Occlusion

Acute Ischemic Stroke
University of Puerto Rico

Not yet recruiting

Using Technology to Improve Function for Older Latinos With Disabilities in Underserved Areas

Aging | Disability Physical

Puerto Rico
Centro Hospitalar e Universitário de Coimbra, E...

Not yet recruiting

Remote Monitoring To Identify Worsening Heart Failure The REMOTI-HF Randomized Clinical Trial (REMOTI-HF)

Heart Failure | Arrythmia
Emory University
National Cancer Institute (NCI)

Not yet recruiting

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage I Pancreatic Cancer AJCC v8 | Resectable Pancreatic Adenocarcinoma | Borderline Resectable Pancreatic Ductal Adenocarcinoma

United States
Taipei Medical University

Recruiting

Smart mHealth Strategy for Physical Activity and Health Promotion

Sedentary Lifestyle | Social Media | Wearable Technology | Health Behavior Change | Chatbot

Taiwan
European Institute of Oncology

Not yet recruiting

Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

Breast Cancer | Neuropathy;Peripheral

Italy
Jinghui Wang

Recruiting

A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.

Lung Cancer

China
Shirley Ryan AbilityLab
University of Alberta

Recruiting

GaMA Metric to Quantify Functional Importance of Various Upper Limb Prosthetic Devices

Amputation | Amputation; Traumatic, Hand | Amputation, Traumatic | Amputation; Traumatic, Limb

United States
University of Strathclyde
Pneumowave Ltd

Not yet recruiting

The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 1 (BREATH-TRACHER)

COPD Exacerbation Acute

United Kingdom
University of Strathclyde
Fourth Frontier Technologies Ltd

Not yet recruiting

The Use of Medical Devices to Monitor Chronic Obstructive Pulmonary Disease Patients Study BREATH-TRACHER 2 (BREATH-TRACHER)

COPD Exacerbation Acute

United Kingdom
Biotheus Inc.

Not yet recruiting

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer

Triple Negative Breast Cancer(TNBC)

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma

Gastric Cancer
Sun Yat-sen University

Not yet recruiting

TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer

Penile Cancer

Search clinical trials for: paclitaxel drug-eluting devices

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations